Gram-Negative Infections in Cancer
Authors:
- Jean KlasterskyJKJean Klastersky
- Alain HenriAHAlain Henri
- Colette HensgensCHColette Hensgens
- Didier DaneauDDDidier Daneau
- 7 January 1974
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 227 (1) , 45-48
Abstract
The combination of carbenicillin disodium and cephalothin sodium was compared in a double-blind study with that of carbenicillin, cephalothin, and gentamicin sulfate therapy in patients with disseminated cancer. These therapies were used empirically prior to recognition of the offending pathogen; however, only infections caused by Gram-negative bacilli were used for the evaluation of the two combinations. A favorable clinical response was observed in 32 (80%) of 40 patients who received carbenicillin and cephalothin and in 31 (76%) of those who received carbenicillin, cephalothin, and gentamicin therapy. The antibacterial activity of the sera of the patients was similar whether the double- or the triple-drug regimen was given. The administration of carbenicillin, cephalothin, and gentamicin was associated with a higher incidence of untoward effects, especially azotemia, than was that of carbenicillin and cephalothin.Keywords
This publication has 4 references indexed in Scilit:
- Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rodsCancer, 1973
- Clinical Significance of In Vitro Synergism Between Antibiotics in Gram-Negative InfectionsAntimicrobial Agents and Chemotherapy, 1972
- Pseudomonas Bacteremia: Pharmacologic and Other Bases for Failure of Treatment with GentamicinThe Journal of Infectious Diseases, 1971
- Antimicrobial Activity of the Carbenicillin/Gentamicin Combination Against Gram-Negative BacilliThe American Journal of the Medical Sciences, 1970